Senior Analyst, Deal Architecture
Danaher Corporation
Summary
The Senior Analyst, Deal Architecture is an integral part of the Global Sales Enablement and Operations team and is responsible for deal creation, financial evaluation, price structure, and contract tracking for Advanced Staining, Core Histology and Pathology Imaging agreements in partnership with our sales teams for Leica Biosystems. You will be responsible for reviewing, drafting, and negotiating commercial offers. Timely, complete, accurate and compliant deal creation is critical to commercial success. This position reports to the Director, Deal Architecture and Governance and is part of the Global Sales Enablement and Operations and is REMOTE.
Job description
In this role, you will have the opportunity to:
- Assist in the creation of deals for Capital, Acquisition, and Rental agreements working alongside sales enablement and other functions to translate into efficient deal closure.
- Analyze contract trends and pricing structures while optimizing deal turnaround times and reviewing margins using tools and continuous improvement methods to streamline processes on proposals.
- Work with Finance to determine any additional charges and costs that relate to agreements.
- Work collaboratively with cross-functional teams, balance internal and external business operation demands, and bring a strong foundation of sales operations, workflow, and improvement experience to the team.
- Review and validate customer offers for accuracy and completeness, maintain an organized database, and ensure all agreement types reflect accurate pricing.
The essential requirements of the job include:
- Bachelor's Degree with a minimum 3 years contracts, medical device sales, or financial analysis experience OR equivalent work experience a minimum 5 years.
- Experience with structuring and reviewing commercial offers with strong business acumen
- Knowledge of medical device industry
- Strong analytical skills with quantitative analysis experience
Travel, Motor Vehicle Record & Physical/Environment Requirements:
- Ability to lift, move or carry equipment up to 10lb
- Ability to travel – 5 % travel
- Must have a valid driver's license and an acceptable Motor Vehicle Record (MVR)
It would be a plus if you also possess previous experience in:
- Masters in relevant subject
- Experience in financial modeling, contracting, marketing and/or sales for consumable and capital acquisition structures, Healthcare GPO/IDN contracts, and managing renewal/agreement amendment activity
Requirements
- Bachelor's Degree with a minimum 3 years contracts, medical device sales, or financial analysis experience OR equivalent work experience a minimum 5 years
- Experience with structuring and reviewing commercial offers with strong business acumen
- Knowledge of medical device industry
- Strong analytical skills with quantitative analysis experience
- Ability to lift, move or carry equipment up to 10lb
- Ability to travel – 5% travel
- Must have a valid driver's license and an acceptable Motor Vehicle Record (MVR)
Benefits
- Paid Time Off
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401(k)
- Bonus/Incentive Pay
- Remote Work
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.